Utah Medical Products (UTMD) declares $0.29/share quarterly dividend, in line with previous.
SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2022 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on October 5, 2022 to …
Utah Medical Products press release (UTMD): Q2 GAAP EPS of $1.12.Revenue of $13.4M (+6.3% Y/Y).
Utah Medical Products (UTMD) declares $0.29/share quarterly dividend, in line with previous.Forward yield 1.39%Payable July 6; for shareholders of record June 17; ex-div June 16.See…
SALT LAKE CITY, UT / ACCESSWIRE / May 10, 2022 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on July 6, 2022 to …
Utah Medical Products press release (UTMD): Q1 GAAP EPS of $0.964.Revenue of $12.32M (+12.4% Y/Y).
The report on Global Postpartum Hemorrhage Treatment Devices Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description contains a []
Salt Lake City, Utah, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Companys stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page.
Related Stocks: UTMD ,
The Latest Intrauterine Pressure Catheters Market Research Report is a comprehensive and in-depth analysis of the global market published by DataIntelo. It provides detailed information about the market, including current trends, drivers and challenges. This report will help companies take a correct business decision and gain competitive advantage in the market. The report covers North []
Related Stocks: UTMD ,
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Gynecological Devices Market Outlook to 2025 - Endometrial Ablation Devices and Female Sterilization Devices" report has been added to ResearchAndMarkets.com's offering. The report covers key market data on the Asia - Pacific Gynecological Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Endometrial Ablation Devices and Female Sterilization Devices. It provides key information an
UTAH MEDICAL PRODUCTS, INC. 7043 South 300 West Midvale,… | February 13, 2020